KOICHI TAKAHASHI to Biomarkers
This is a "connection" page, showing publications KOICHI TAKAHASHI has written about Biomarkers.
Connection Strength
0.035
-
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia. 2020 11; 34(11):2914-2924.
Score: 0.020
-
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. Am J Hematol. 2017 Jul; 92(7):599-606.
Score: 0.016